 Connection
Jost Klawitter to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Jost Klawitter has written about Dose-Response Relationship, Drug.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.118 |
|
|
|
-
Wolinsky D, Srungaram D, Zhang A, Moore CF, Pierce-Messick ZJ, Zamarripa CA, Spindle TR, Strickland JC, Sempio C, Klawitter J, Campos Palomino J, Christians U, Feldner MT, Vandrey R, Bonn-Miller MO, Weerts EM, Bergeria CL. Safety, pharmacodynamics, and pharmacokinetics of oral cannabigerol in healthy adults. J Pharmacol Exp Ther. 2026 Aug; 393(8):104984.
Score: 0.044
-
Moore CF, Bergeria CL, Sempio C, Klawitter J, Christians U, Weerts EM. High doses of orally administered cannabigerol produce deficits in sustained attention in female rats. Pharmacol Biochem Behav. 2026 Mar; 260:174154.
Score: 0.042
-
Peters EN, MacNair L, Mosesova I, Christians U, Sempio C, Klawitter J, Land MH, Ware MA, Turcotte C, Bonn-Miller MO. Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and ?9-tetrahydrocannabinol: a pilot study. Eur J Clin Pharmacol. 2022 Feb; 78(2):259-265.
Score: 0.032
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|